Literature DB >> 33767730

Structural and Drug Screening Analysis of the Non-structural Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 Virus Extracted From Indian Coronavirus Disease 2019 Patients.

Nupur Biswas1, Krishna Kumar1, Priyanka Mallick1, Subhrangshu Das1, Izaz Monir Kamal1, Sarpita Bose1, Anindita Choudhury1, Saikat Chakrabarti1.   

Abstract

The novel coronavirus 2 (nCoV2) outbreaks took place in December 2019 in Wuhan City, Hubei Province, China. It continued to spread worldwide in an unprecedented manner, bringing the whole world to a lockdown and causing severe loss of life and economic stability. The coronavirus disease 2019 (COVID-19) pandemic has also affected India, infecting more than 10 million till 31st December 2020 and resulting in more than a hundred thousand deaths. In the absence of an effective vaccine, it is imperative to understand the phenotypic outcome of the genetic variants and subsequently the mode of action of its proteins with respect to human proteins and other bio-molecules. Availability of a large number of genomic and mutational data extracted from the nCoV2 virus infecting Indian patients in a public repository provided an opportunity to understand and analyze the specific variations of the virus in India and their impact in broader perspectives. Non-structural proteins (NSPs) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) virus play a major role in its survival as well as virulence power. Here, we provide a detailed overview of the SARS-CoV2 NSPs including primary and secondary structural information, mutational frequency of the Indian and Wuhan variants, phylogenetic profiles, three-dimensional (3D) structural perspectives using homology modeling and molecular dynamics analyses for wild-type and selected variants, host-interactome analysis and viral-host protein complexes, and in silico drug screening with known antivirals and other drugs against the SARS-CoV2 NSPs isolated from the variants found within Indian patients across various regions of the country. All this information is categorized in the form of a database named, Database of NSPs of India specific Novel Coronavirus (DbNSP InC), which is freely available at http://www.hpppi.iicb.res.in/covid19/index.php.
Copyright © 2021 Biswas, Kumar, Mallick, Das, Kamal, Bose, Choudhury and Chakrabarti.

Entities:  

Keywords:  COVID-19; SARS-CoV2; database; mutation; non-structural proteins

Year:  2021        PMID: 33767730      PMCID: PMC7985531          DOI: 10.3389/fgene.2021.626642

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  5 in total

1.  The impact of the suppression of highly connected protein interactions on the corona virus infection.

Authors:  Felipe Torres; Miguel Kiwi; Ivan K Schuller
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

2.  Genomic Surveillance and Phylodynamic Analyses Reveal the Emergence of Novel Mutations and Co-mutation Patterns Within SARS-CoV-2 Variants Prevalent in India.

Authors:  Nupur Biswas; Priyanka Mallick; Sujay Krishna Maity; Debaleena Bhowmik; Arpita Ghosh Mitra; Soumen Saha; Aviral Roy; Partha Chakrabarti; Sandip Paul; Saikat Chakrabarti
Journal:  Front Microbiol       Date:  2021-07-29       Impact factor: 5.640

3.  Non-structure protein ORF1ab (NSP8) in SARS-CoV-2 contains potential γδT cell epitopes.

Authors:  Boyu Du; Yang Guo; Gang Li; Yunhe Zhu; Yunfu Wang; Xueyan Xi
Journal:  Front Microbiol       Date:  2022-07-22       Impact factor: 6.064

4.  In Silico Studies on Zinc Oxide Based Nanostructured Oil Carriers with Seed Extracts of Nigella sativa and Pimpinella anisum as Potential Inhibitors of 3CL Protease of SARS-CoV-2.

Authors:  Awatif A Hendi; Promy Virk; Manal A Awad; Mai Elobeid; Khalid M O Ortashi; Meznah M Alanazi; Fatemah H Alkallas; Maha Mohammad Almoneef; Mohammed Aly Abdou
Journal:  Molecules       Date:  2022-07-04       Impact factor: 4.927

Review 5.  SARS-CoV-2 Mutations and Their Impact on Diagnostics, Therapeutics and Vaccines.

Authors:  Suresh Thakur; Shalitha Sasi; Sindhu Gopinathan Pillai; Ayantika Nag; Dhananjay Shukla; Ritu Singhal; Sameer Phalke; G S K Velu
Journal:  Front Med (Lausanne)       Date:  2022-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.